Byung-Ki Cho
Vorstandsvorsitzender bei BIONOTE, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Byung-Ki Cho is currently the Chief Executive Officer & Director at BioNote, Inc. He previously worked as the Director & Head-Research Center at Abbott Diagnostics Korea, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SD BIOSENSOR, INC.
0,12% | 28.03.2024 | 150 000 ( 0,12% ) | 1 Mio $ | 30.04.2024 |
Aktive Positionen von Byung-Ki Cho
| Unternehmen | Position | Beginn |
|---|---|---|
| BIONOTE, INC. | Vorstandsvorsitzender | 01.08.2020 |
Ehemalige bekannte Positionen von Byung-Ki Cho
| Unternehmen | Position | Ende |
|---|---|---|
Abbott Diagnostics Korea, Inc.
 Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIONOTE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
